pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,901 catalysts · 5,901 phase readout · 2,311 8k filing · 420 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 42 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 16 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: filing×clear all
type
  • phase readout5,901
  • 8k filing2,311
  • earnings420
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT04346238: Characterization of the Interruptions of the GAA Expansion and Study of Their Influence on the Severity of Friedreich's Ataxia

Sponsor: University Hospital, Montpellier. Phase: . Conditions: Friedreich Ataxia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07570758: A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Sponsor: ERX Pharmaceuticals. Phase: PHASE2. Conditions: Obesity & Overweight

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06586658: Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Sponsor: Shanghai Changzheng Hospital. Phase: EARLY_PHASE1. Conditions: Renal Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT03651648: Apnea Treatment in Premature Infants Using an Automatic Vibro-tactile Stimulator Triggered by the Detection of Apnea-bradycardia.

Sponsor: Rennes University Hospital. Phase: NA. Conditions: Apnea of Prematurity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06428448: Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections

Sponsor: OsteoRemedies, LLC. Phase: PHASE2. Conditions: Periprosthetic Joint Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07105449: THC Titration of High-Potency Cannabis Concentrates

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: THC

full page →ctgov ↗
›RECRUITINGphase readoutNCT06212349: Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis.

Sponsor: University of Valencia. Phase: NA. Conditions: Endometriosis, Chronic Pain, Women's Health

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07676526: Association Between Chronic Kidney Disease Stage and Circulating FGF23 Cleavage Intensity in Patients With Chronic Kidney Disease

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: CKD - Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07615478: Effect of Hot Spring Therapy on Central Fatigue Elimination During Altitude Training

Sponsor: Macao Polytechnic University. Phase: NA. Conditions: Central Fatigue, Altitude Training, Cognitive Impairment, Hydrotherapy, Balneotherapy, Sports Performance

full page →ctgov ↗
›RECRUITINGphase readoutNCT07677878: Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL

Sponsor: Liping Dou. Phase: PHASE1. Conditions: ALL (Acute B-Lymphoblastic Leukemia)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06983743: A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Sponsor: Erasca, Inc.. Phase: PHASE1. Conditions: Metastatic Solid Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT05133440: A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07515768: TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Aortic Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06423768: fMRI in CardiaC arrEst With Uncertain Prognosis

Sponsor: Brigham and Women's Hospital. Phase: . Conditions: Cardiac Arrest

full page →ctgov ↗
›TERMINATEDphase readoutNCT06987968: A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Sponsor: Genfit. Phase: PHASE2. Conditions: Hepatic Encephalopathy, Acute on Chronic Liver Failure (ACLF), Decompensated Cirrhosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT02233868: Brain Inflammation and Function in Alcoholism

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA). Phase: EARLY_PHASE1. Conditions: Alcohol Use Disorder (AUD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06557668: Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer

Sponsor: Taichung Veterans General Hospital. Phase: . Conditions: Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05440890: Early Treatment Based Neuroscience Education in Knee

Sponsor: University of Malaga. Phase: NA. Conditions: Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Injuries

full page →ctgov ↗
›RECRUITINGphase readoutNCT06102590: Oxygen Extraction-guided Transfusion

Sponsor: Università degli Studi di Ferrara. Phase: NA. Conditions: Blood Transfusion

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07742618: Effectiveness of AI-Assisted Clinical Documentation

Sponsor: University of Turku. Phase: NA. Conditions: Effectiveness of AI-assisted Clinical Documentation Tool, Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06952790: Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study

Sponsor: University of Miami. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05141890: Probiotics for Inflammation in Pediatric Chronic Pain

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Chronic Pain, Body Mass Index >=85th Percentile

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07748390: Pain and Anxiety During Vital Pulp Therapy Using Different Local Anesthesia Techniques in Children

Sponsor: Recep Tayyip Erdogan University Training and Research Hospital. Phase: . Conditions: Pediatric, Anesthesia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07193290: A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies

Sponsor: Kenvue Brands LLC. Phase: . Conditions: Skin Aging, Hair Care, Skin Microbiome

full page →ctgov ↗
›COMPLETEDphase readoutNCT06784310: Food Insecurity, Social Determinants of Health

Sponsor: Alison Gustafson. Phase: NA. Conditions: Food Insecurity, Type 2 Diabetes Mellitus (T2DM), Hypertension

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07408960: CO2Lift and T-Junction Breakdown Rates Evaluation After Breast Reduction Surgery Pilot Trial

Sponsor: University of Calgary. Phase: NA. Conditions: Wound Breakdown, Breast Reduction, Surgical Wound, Breast Surgery

full page →ctgov ↗
›COMPLETEDphase readoutNCT06493682: The Effect of Motivational Interviewing in Women's Health

Sponsor: Amasya University. Phase: NA. Conditions: Procrastination, Health Behavior, Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07092423: Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.

Sponsor: Tang-Du Hospital. Phase: NA. Conditions: Traumatic Brain Injury, Neurocritical Care, Enteral Feeding Intolerance

full page →ctgov ↗
›COMPLETEDphase readoutNCT07275723: A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd. Phase: PHASE3. Conditions: For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07667023: Virtual Reality Headset as an Alternative Tool for Reducing Dental Anxiety

Sponsor: Semmelweis University. Phase: NA. Conditions: Neurodevelopmental Disorder (Diagnosis)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07417059: Sex Hormones Impact on Cannabis Response

Sponsor: Maastricht University. Phase: NA. Conditions: Cannabis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07431723: Creation of Compression Anastomosis Using the GT Metabolic Magnet System

Sponsor: GT Metabolic Solutions, Inc.. Phase: NA. Conditions: Anastomosis, Functional, Colorectal

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04229459: Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.

Sponsor: Baruch Brenner. Phase: PHASE2. Conditions: Esophageal Squamous Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06227780: Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: NA. Conditions: Fragile X Syndrome, Autism Spectrum Disorder, Autistic Disorder, Asperger Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07595380: Empowering Postpartum Health Through Exercise

Sponsor: University of Rome Foro Italico. Phase: NA. Conditions: No Condition, Healthy Females

full page →ctgov ↗
›RECRUITINGphase readoutNCT06325696: H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: PHASE2. Conditions: Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial

full page →ctgov ↗
›RECRUITINGphase readoutNCT07569588: Improving Patient Assessment After Acute Kidney Injury (AKI)

Sponsor: University of Nottingham. Phase: . Conditions: Acute Kidney Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07634588: ACUTE EFFECT OF DIAPHRAGMATIC BREATHING ON POSTOPERATIVE UPPER TRAPEZIUS PAIN

Sponsor: Istanbul Aydın University. Phase: NA. Conditions: Neck Pain, Myofascial Pain Syndrome, Work-Related Musculoskeletal Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT04236388: Short Term Ketone Supplementation and Cardiometabolic Health

Sponsor: Virginia Polytechnic Institute and State University. Phase: NA. Conditions: Cardiovascular Risk Factor

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07374588: Impact of Medication Education on Adherence and Side Effects

Sponsor: Cumhuriyet University. Phase: NA. Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder With Psychotic Features, Major Depressive Disorder With Psychotic Features

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04075903: Gout in the ED and Improving Research Participation

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Gout

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05060627: Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

Sponsor: PETHEMA Foundation. Phase: PHASE1. Conditions: Relapsed Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06755827: Pilot Testing a Novel Approach to Pediatric Obesity Treatment

Sponsor: Texas Tech University. Phase: PHASE1. Conditions: Overweight Adolescents, Obese Adolescents

full page →ctgov ↗
›RECRUITINGphase readoutNCT07013461: International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Sponsor: The University of Hong Kong-Shenzhen Hospital. Phase: . Conditions: Nasopharyngeal Cancinoma (NPC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524127: Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Polymorphonuclear Cells in the Middle Turbinate

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07577661: Combination Upper-Airway Electrical and Pharmacological Stimulation for Obstructive Sleep Apnea

Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Obstructive Sleep Apnea, Sleep-disordered Breathing

full page →ctgov ↗
›COMPLETEDphase readoutNCT07488286: Playful Physical Activity Program and Executive Function in Preschool Children

Sponsor: Monira Aldhahi. Phase: NA. Conditions: Executive Function, School Readiness

full page →ctgov ↗
›RECRUITINGphase readoutNCT06737770: Clinical and Functional Assessment of Patients With Transfemoral Amputation Treated With Osteointegrated Implant

Sponsor: Istituto Ortopedico Rizzoli. Phase: NA. Conditions: Prosthesis, Lower Limb Amputation Knee, Amputation; Traumatic, Leg, Lower

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05889273: ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

Sponsor: MapLight Therapeutics. Phase: PHASE2. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07333573: A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer

Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE1. Conditions: Stage IV Gastric Cancer

full page →ctgov ↗
← prev
page 117 of 119
next →